Chemopreventive Agent Development Clinical Trials
Title |
Intervention | NCT ID | Sponsor | Status |
|---|---|---|---|---|
| Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's... | placebo, defined green tea catechin extract | NCT00233935 | National Cancer Institute (NCI) | Completed |
| Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer | placebo, genistein, laboratory biomarker analysis | NCT00290758 | National Cancer Institute (NCI) | Completed |
| Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer | letrozole, quality-of-life assessment, laboratory biomarker analysis | NCT01077453 | National Cancer Institute (NCI) | Completed |
| Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch... | Laboratory Biomarker Analysis, Naproxen, Placebo | NCT02052908 | National Cancer Institute (NCI) | Active, not recruiting |
| Resveratrol in Healthy Adult Participants | resveratrol, pharmacological study, laboratory biomarker analysis | NCT00721877 | National Cancer Institute (NCI) | Completed |
| Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients | Se-methyl-seleno-L-cysteine, placebo, pharmacological study, laboratory biomarker analysis | NCT00489372 | National Cancer Institute (NCI) | Completed |
| Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy... | Selenium, Placebo, Laboratory Biomarker Analysis, Pharmacological Study, Methylselenocysteine | NCT01497431 | National Cancer Institute (NCI) | Completed |
| Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and... | Laboratory Biomarker Analysis, Soy Isoflavones, Survey Administration | NCT02007200 | National Cancer Institute (NCI) | Completed |
| Studying Different Formulations of SR13668 in Healthy Volunteers | Akt inhibitor SR13668 | NCT00896207 | National Cancer Institute (NCI) | Completed |
| Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome... | tazarotene, placebo | NCT00783965 | Children's Hospital & Research Center Oakland | Completed |